---
title: "Portfolio | MintPharma Capital"
description: "Portfolio companies across the life sciences ecosystem — therapeutics, cell therapy, drug delivery and diagnostics backed by MintPharma Capital."
lang: en
json-ld: |
  [
    {
      "@context": "https://schema.org",
      "@type": "FinancialService",
      "name": "MintPharma Capital",
      "description": "Biotech and life sciences venture capital fund investing $2-7 million as lead investor in seed and Series A rounds.",
      "areaServed": "United States",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Boca Raton",
        "addressRegion": "FL",
        "addressCountry": "US"
      },
      "founder": [
        {
          "@type": "Person",
          "name": "Robert G. Finizio"
        },
        {
          "@type": "Person",
          "name": "David Adams"
        }
      ],
      "knowsAbout": [
        "Biotech venture capital",
        "Life sciences investing",
        "Pharmaceutical development",
        "Medical device investing",
        "Seed and Series A financing"
      ],
      "parentOrganization": {
        "@type": "Organization",
        "name": "Mint12 LLC",
        "url": "https://www.mint12.com"
      }
    },
    {
      "@context": "https://schema.org",
      "@type": "ItemList",
      "name": "MintPharma Capital Portfolio",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "item": {
            "@type": "Organization",
            "name": "Myosin Therapeutics",
            "url": "/portfolio/myosin-therapeutics"
          }
        },
        {
          "@type": "ListItem",
          "position": 2,
          "item": {
            "@type": "Organization",
            "name": "PleoPharma",
            "url": "/portfolio/pleopharma"
          }
        },
        {
          "@type": "ListItem",
          "position": 3,
          "item": {
            "@type": "Organization",
            "name": "NOXX Therapeutics",
            "url": "/portfolio/noxx-therapeutics"
          }
        },
        {
          "@type": "ListItem",
          "position": 4,
          "item": {
            "@type": "Organization",
            "name": "ICaPath",
            "url": "/portfolio/icapath"
          }
        },
        {
          "@type": "ListItem",
          "position": 5,
          "item": {
            "@type": "Organization",
            "name": "Vycellix",
            "url": "/portfolio/vycellix"
          }
        },
        {
          "@type": "ListItem",
          "position": 6,
          "item": {
            "@type": "Organization",
            "name": "Astrocyte",
            "url": "/portfolio/astrocyte"
          }
        },
        {
          "@type": "ListItem",
          "position": 7,
          "item": {
            "@type": "Organization",
            "name": "Vinci Pharmaceuticals",
            "url": "/portfolio/vinci-pharmaceuticals"
          }
        },
        {
          "@type": "ListItem",
          "position": 8,
          "item": {
            "@type": "Organization",
            "name": "NanoRap",
            "url": "/portfolio/nanorap"
          }
        },
        {
          "@type": "ListItem",
          "position": 9,
          "item": {
            "@type": "Organization",
            "name": "Baylor Genetics",
            "url": "/portfolio/baylor-genetics"
          }
        }
      ]
    }
  ]
---

[![MintPharma Capital](/__l5e/assets-v1/1538914d-2de5-4bae-910b-e2516763b401/MintPharmaCapital_LOGO.png)](/)

-   [About Us](/about)
-   [Strategy](/our-strategy)
-   [Portfolio](/our-portfolio)
-   [Team](/our-team)

[Get in Touch](/contact)

Portfolio

# Backing Healthcare Innovation

[

![Myosin Therapeutics logo](/assets/logo-myosin--6Gldt4C.png)

### Myosin Therapeutics

Novel therapeutics targeting non-muscle myosin biology for oncology and CNS disease.

](https://www.myosintherapeutics.com/)[

![PleoPharma logo](/assets/logo-pleopharma-CrkOqyax.png)

### PleoPharma

Late-stage development of a pioneering therapy for cannabis withdrawal.

](https://www.pleopharma.com/)

![NOXX Therapeutics logo](/assets/logo-noxx-BMnPoobz.png)

### NOXX Therapeutics

Monoclonal antibody therapies that restore immune function in the tumor microenvironment.

[

![ICaPath logo](/assets/logo-icapath-QlXyWs3q.png)

### ICaPath

Nanoparticle-based immunotherapy delivery for precise, sustained cytokine dosing.

](https://icapath.com/)[

![Vycellix logo](/assets/logo-vycellix-7Pcxe2bR.jpg)

### Vycellix

Advancing next-generation NK cell therapies for cancer.

](https://vycellix.com/)[

![Astrocyte logo](/assets/logo-astrocyte-CTlD2_qW.png)

### Astrocyte

Small-molecule cerebroprotectants for concussion, traumatic brain injury, and stroke.

](https://www.astrocytepharma.com/)[

![Vinci Pharmaceuticals logo](/__l5e/assets-v1/1486b1cf-bf5d-4c22-913e-c41139712f70/vinci-pharmaceuticals-logo.png)

### Vinci Pharmaceuticals

Sustained-release delivery systems for retinal disease therapy.

](https://www.vincipharmaceuticals.com/)[

![NanoRap logo](/__l5e/assets-v1/958e0abc-9770-4eeb-a809-7b566c848cdf/nanorap-logo.png)

### NanoRap

Early-stage, pre-clinical research on Rapamycin and aging.

](https://nanorapco.com/)[

![Baylor Genetics logo](/__l5e/assets-v1/799ebc74-0ed0-405f-a259-0f261b62b5b4/baylor-genetics-logo.png)

### Baylor Genetics

Providing advanced genetic testing and rare disease diagnostics.

](https://www.baylorgenetics.com/)

Connect With Us

Reach out to the MintPharma Capital team.

[Get in Touch](/contact)

![MintPharma Capital](/__l5e/assets-v1/1538914d-2de5-4bae-910b-e2516763b401/MintPharmaCapital_LOGO.png)

## Explore

-   [Strategy](/our-strategy)
-   [Portfolio](/our-portfolio)
-   [Team](/our-team)

## Connect

-   [Get in Touch](/contact)

© 2026 MintPharma Capital. All rights reserved.

This site is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security.

[Get in Touch](/contact)